Cerebral Small Vessel Disease in Kathmandu — Silent Brain Changes and Prevention

Cerebral small vessel disease (CSVD) refers to damage to the small blood vessels in the brain — arterioles, capillaries, and venules. This damage produces characteristic changes on brain imaging including white matter hyperintensities, lacunar infarcts, cerebral microbleeds, and enlarged perivascular spaces. While CSVD often progresses silently, it is a major contributor to stroke, cognitive decline, and gait disorders in older adults.

The most common cause of CSVD is chronic hypertension, which damages small vessel walls over decades. Other contributors include diabetes, smoking, aging, and genetic factors. The resulting vessel changes include thickening of vessel walls (arteriolosclerosis), reduced vessel elasticity, and impaired blood flow regulation. These changes lead to chronic hypoperfusion, blood-brain barrier disruption, and eventually ischemic damage to white matter.

Dr. Jitendra Prasad Yadav — consultant neurologist & headache specialist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for stroke & tia.

CSVD is often detected incidentally on brain MRI performed for other reasons. White matter hyperintensities appear as bright spots on T2-weighted MRI sequences, particularly in the periventricular and deep white matter. Lacunar infarcts are small (less than 15 mm) areas of damage in deep brain structures such as the basal ganglia, thalamus, and pons. Cerebral microbleeds appear as small dark spots on susceptibility-weighted imaging.

Clinical manifestations vary. Many people with CSVD have no symptoms despite extensive imaging changes. When symptoms occur, they may include cognitive impairment (particularly slowed processing speed and executive dysfunction), gait disturbance and balance problems, mood changes including depression and apathy, and an increased risk of both ischemic and hemorrhagic stroke. CSVD is a leading cause of vascular cognitive impairment and vascular dementia.

Diagnosis is primarily based on MRI findings. The severity of CSVD is often graded using scales such as the Fazekas scale for white matter hyperintensities. Clinical correlation is essential — not all white matter changes are clinically significant, and the same imaging findings may have different implications depending on the patient's age and clinical presentation.

Treatment focuses on aggressive vascular risk factor control. Blood pressure management is the single most important intervention — targets are typically lower than for primary stroke prevention. Tight diabetes control, smoking cessation, lipid management, and regular exercise all contribute to slowing CSVD progression. Antiplatelet therapy may be considered for secondary stroke prevention but must be balanced against microbleed risk.

At Kathmandu Neurology Clinic & Cognitive Center, Dr. Jitendra Prasad Yadav (NMC 8029) evaluates CSVD in the context of cognitive impairment, gait disorders, or stroke prevention. The emphasis is on identifying modifiable risk factors and implementing aggressive prevention strategies.

This article is educational and does not replace individual medical advice.

**Frequently Asked Questions**

Q: Is cerebral small vessel disease reversible? A: The structural changes of CSVD are generally not reversible, but progression can be slowed significantly with aggressive vascular risk factor control. Some clinical symptoms, particularly cognitive function, may stabilize or improve when risk factors are optimally managed.

Q: What causes cerebral small vessel disease? A: The most important cause is chronic hypertension. Other contributors include diabetes, smoking, aging, hyperlipidemia, and genetic factors. These cause damage to small vessel walls over many years, leading to the characteristic imaging findings.

Q: Does cerebral small vessel disease cause memory loss? A: CSVD typically causes slowed thinking and executive dysfunction rather than the prominent memory loss seen in Alzheimer's disease. However, CSVD frequently coexists with Alzheimer's pathology, and the combination produces more severe cognitive impairment than either condition alone.

Q: How is cerebral small vessel disease treated? A: Treatment focuses on aggressive vascular risk factor control: blood pressure management, diabetes control, smoking cessation, lipid management, and regular exercise. Antiplatelet therapy may be used for stroke prevention when appropriate. There are no specific medications that directly treat CSVD.

Q: Can cerebral small vessel disease cause stroke? A: Yes, CSVD significantly increases the risk of both ischemic and hemorrhagic stroke. Lacunar infarcts (small deep strokes) are a direct manifestation of CSVD. The presence of CSVD on imaging is an independent risk factor for future stroke.

Q: Should cerebral small vessel disease be treated if there are no symptoms? A: Even asymptomatic CSVD warrants attention because it indicates increased risk of future stroke and cognitive decline. Vascular risk factor control is recommended regardless of symptoms, with treatment intensity individualized based on overall risk profile.